Exicure, Inc. (XCUR): Price and Financial Metrics
XCUR Price/Volume Stats
| Current price | $0.58 | 52-week high | $1.50 |
| Prev. close | $0.60 | 52-week low | $0.36 |
| Day low | $0.57 | Volume | 23,800 |
| Day high | $0.61 | Avg. volume | 406,915 |
| 50-day MA | $0.62 | Dividend yield | N/A |
| 200-day MA | $0.71 | Market Cap | 5.01M |
XCUR Stock Price Chart Interactive Chart >
Exicure, Inc. (XCUR) Company Bio
Exicure, Inc. operates as a clinical stage bio-technology company. The Company develops a new class of immunomodulatory and gene regulating drugs against validated targets, as well as addresses diseases such as oncology, immunology, and dermatology. Exicure serves customers in the United States.
Latest XCUR News From Around the Web
Below are the latest news stories about EXICURE INC that investors may wish to consider to help them evaluate XCUR as an investment opportunity.
Why Is Avid Bioservices (CDMO) Stock Down 18% Today?Avid Bioservices stock is falling hard on Friday as investors in CDMO react to a lackluster earnings report and a guidance cut. |
Why Is Exicure (XCUR) Stock Up 57% Today?Exicure stock is rising higher on Friday with heavy trading of XCUR shares despite a lack of news from the biotechnology company. |
Why Is HashiCorp (HCP) Stock Down 22% Today?HashiCorp stock is falling on Friday even as HCP beat out Wall Street's adjusted EPS and revenue estimates for Q3 of fiscal 2024. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! |
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-QCHICAGO, November 28, 2023--Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on November 22, 2023 notifying the Company that, as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023 (the "Form 10-Q"), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule"), which requires listed companies |
XCUR Price Returns
| 1-mo | -7.36% |
| 3-mo | -3.33% |
| 6-mo | -12.12% |
| 1-year | -42.00% |
| 3-year | -98.84% |
| 5-year | -99.29% |
| YTD | -0.05% |
| 2023 | -49.54% |
| 2022 | -81.03% |
| 2021 | -88.58% |
| 2020 | -38.11% |
| 2019 | -19.21% |
Continue Researching XCUR
Want to do more research on Exicure Inc's stock and its price? Try the links below:Exicure Inc (XCUR) Stock Price | Nasdaq
Exicure Inc (XCUR) Stock Quote, History and News - Yahoo Finance
Exicure Inc (XCUR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...